<p>Paul de Figueiredo and colleagues at Texas A&amp;M University in the U.S. propose to develop a system whereby drugs for defeating new antibiotic-resistant strains of Mycobacterium tuberculosis can be developed in the laboratory before these strains emerge in human populations.</p>


Paul de Figueiredo and colleagues at Texas A&amp;M University in the U.S. propose to develop a system whereby drugs for defeating new antibiotic-resistant strains of Mycobacterium tuberculosis can be developed in the laboratory before these strains emerge in human populations.